Skip to main content
. 2021 Oct 25;11:723840. doi: 10.3389/fcimb.2021.723840

Table 1.

Characteristics of the NCI and non-NCI groups (n = 102).

Characteristics NCI group (n = 67) Non-NCI group (n = 35) P-values
Demographics
Sex, n (%)
 Male 55 (82.1) 25 (71.4) 0.186
 Female 12 (17.9) 10 (29.4)
Age, years, (mean ± SD) 54.6 ± 9.7 55.3 ± 9.3 0.708
BMI, kg/m2 (mean ± SD) 23.2 ± 3.0 22.9 ± 2.6 0.679
Education, n (%)
 ≤Primary school 49 (70.0) 20 (49.0) 0.297
 Middle school 13 (19.4) 11 (31.4)
 ≥High school 5 (7.5) 4 (8.6)
Current smoker, n (%)
 Yes 35 (52.2%) 13 (37.1%) 0.107
 No 32 (47.8%) 22 (62.9%)
Current alcohol use, n (%)
 Yes 26 (38.8%) 14 (40.0%) 0.956
 No 41 (61.2%) 21 (60.0%)
HIV-related characteristics
Time since HIV diagnosis, years, (median, IQR) 5.2 (3.8, 8.2) 4.8 (3.2, 7.5) 0.782
Duration on cART, years (median, IQR) 4.3 (3.7, 6.3) 4.0 (2.9, 7.6) 0.578
Sexual preference (homosexual, %) 14 (20.9%) 9 (25.7%) 0.554
Current CD4 count, cells/μl (mean ± SD) 414.9 ± 194.9 472.2 ± 230.5 0.215
Clinical symptom
 Hypertension 32 (47.7%) 15 (42.8%) 0.572
 History of diabetes 6 (9.0%) 2 (5.7%) 0.569
 Depressive symptoms 27 (40.3%) 13 (37.1%) 0.759
 Insomnia symptoms 13 (19.4%) 5 (14.3%) 0.510
 Frailty symptoms 18 (26.9%) 10 (28.6%) 0.858
Laboratory biomarkers
 HDL (median, IQR) 1.2 (0.9, 1.5) 1.2 (1.0, 1.5) 0.736
 LDL (median, IQR)
 CHOL (median, IQR)
2.3 (1.8, 2.9)
4.7 (3.9, 5.4)
2.5 (2.1, 3.0)
4.5 (3.9, 4.9)
0.401
0.242
 TG (median, IQR) 2.0 (1.2, 3.2) 1.7 (1.0, 3.0) 0.371
 Left CIMT (median, IQR) 1.1 (0.7, 1.4) 0.9 (0.8, 1.0) 0.017*
 Right CIMT (median, IQR) 1.2 (0.8, 1.2) 0·9 (0.8, 1.0) 0.008**
 Carotid plaques, n (%)
 Yes 36 (53.7%) 9 (25.7%) 0.007**
 No 31 (46.3%) 26 (74.3%)
 Cholesterol crystal, n (%)
 Yes 20 (29.9%) 1 (2.9%) 0.001**
 No 47 (70.1%) 34 (52.2%)

NCI, neurocognitive impairment; BMI, body mass index; CIMT, carotid intima-media thickness; IQR, interquartile range; SD, standard deviation.

*P < 0.05; **P < 0.01.